REFERENCES
- Hepler CD. Unresolved issues in the future of pharmacy. Am J Hosp Pharm 1988;45:1071–81.
- Giorgianni Si. "Dosage form" definition may limit generic use. NABP Newsl 1994;23(9):116.
- Schuber S. An interview with Sir James Black. Pharm Tech 1989; 13(3):48+.
- Hepler CD. The third wave in pharmaceutical education: the clinical movement. Am J Pharm Educ 1987;51:369–85.
- Benson H, Mader W. Drug dosage forms. J Pharm Sci 1977;66:VIII.
- Chien YW, Robinson JR. "Smart" drug-delivery systems. J Parenter Sci Technol 1982;36:231.
- Sante11 JP. Projecting future drug expenditures-1995. Am J Health-Syst Pharm 1995;52: 151–63.
- Weintraub M. The alternative drug delivery systems market. P&T 1992;17:167.
- Newton DW. Pharmaceutical technology and drug therapy outcomes. APhA-APRS Acad Reporter 1995;3(1):in press.
- Johnson NE. Phannacoeconomics and biotech drugs. P&T 1992;17:1402–12.
- Dibner MD. U.S. biotechnology and pharmaceuticals. BioPharm 1992;5(8):24–8.
- Ratafia M. Drug delivery: the key to biotechnology markets. Med Market Media 1989;24(Oct 1):11–21.
- Langer R. New methods of drug delivery. Science 1990;249:1527–33.
- Robinson DH, Mauger JW. Drug delivery systems. Am J Hosp Pharm 1991;48 (Suppl 1):S14–S23.
- Piascik MM. Research and development of drugs and biologic entities. Am 1 Hosp Pharrn 1991;48\(Suppl 1):S4–S13.
- Traynor K, Newton DW, Hrusheslcy WJM, Reiter RI. A pharmacist's prim-er on chronotherapeutics. Am Pharm 1992;NS32:261–9.
- Newton DW. Prospects for controlled-delivery systems. Am Pharrn 1992NS32: 989–93.
- Newton DW. Biotechnology and controlled drug delivery. US Pharm 1991;16 (6):38+.
- Maibach HI. Review of Skin Permeation Fundamentals and Application. J Pharm Sci 1994;83:1524.